Literature DB >> 22365915

Laboratory-acquired brucellosis in Turkey.

S Sayin-Kutlu1, M Kutlu, O Ergonul, S Akalin, T Guven, Y Z Demiroglu, O Acicbe, M Akova.   

Abstract

BACKGROUND: Laboratory healthcare workers (HCWs) are at risk of laboratory-acquired brucellosis (LAB). AIM: To describe the risk factors of LAB among HCWs.
METHODS: A multicentre survey study was conducted by face-to-face interview in 38 hospitals from 17 provinces of Turkey. A structured survey was administered to the HCWs, working in infectious diseases clinics and microbiology departments, who were at risk of brucella infection.
FINDINGS: The survey response rate was 100%. Of the 667 laboratory workers, 38 (5.8%) had a history of LAB. In multivariate analysis, factors independently associated with an increased risk of LAB included working with the brucella bacteria (odds ratio: 5.12; 95% confidence interval: 2.28-11.52; P < 0.001) and male gender (2.14; 1.02-4.45; P = 0.042). Using a biosafety cabinet level 2 (0.13; 0.03-0.60; P = 0.009), full adherence to glove use (0.27; 0.11-0.65; P = 0.004) and longer duration of professional life (0.86; 0.80-0.92; P < 0.001) were found to be protective.
CONCLUSIONS: Working with the brucella bacteria, being male, a lack of compliance with personal protective equipment and biosafety cabinets were the independent risk factors for the development of LAB in our series. Increased adherence to personal protective equipment and use of biosafety cabinets should be priority targets to prevent LAB. Copyright Â
© 2012 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22365915     DOI: 10.1016/j.jhin.2011.12.020

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  8 in total

1.  A high percentage of serum samples that test reactive by enzyme immunoassay for anti-Brucella antibodies are not confirmed by the standard tube agglutination test.

Authors:  Matthew J Binnicker; Elitza S Theel; Staci M Larsen; Robin Patel
Journal:  Clin Vaccine Immunol       Date:  2012-06-20

Review 2.  Brucellosis in low-income and middle-income countries.

Authors:  Matthew P Rubach; Jo E B Halliday; Sarah Cleaveland; John A Crump
Journal:  Curr Opin Infect Dis       Date:  2013-10       Impact factor: 4.915

3.  Laboratory-acquired dengue virus infection by needlestick injury: a case report, South Korea, 2014.

Authors:  Changhwan Lee; Eun Jung Jang; Donghyok Kwon; Heun Choi; Jung Wan Park; Geun-Ryang Bae
Journal:  Ann Occup Environ Med       Date:  2016-04-07

4.  Status of Laboratory Biosafety and Biosecurity in Veterinary Research Facilities in Nigeria.

Authors:  Ismail Ayoade Odetokun; Afusat Toyin Jagun-Jubril; Bernard A Onoja; Yiltawe Simwal Wungak; Ibrahim Adisa Raufu; Jessica Corron Chen
Journal:  Saf Health Work       Date:  2016-08-26

5.  Early diagnosis and treatment of acute brucellosis knee arthritis complicated by acute osteomyelitis: two cases report.

Authors:  Jie Wang; Qiang Zhang
Journal:  BMC Infect Dis       Date:  2022-05-04       Impact factor: 3.667

6.  Hospital-associated transmission of Brucella melitensis outside the laboratory.

Authors:  Christopher F Lowe; Adrienne J Showler; Suzette Perera; Susan McIntyre; Roohi Qureshi; Samir N Patel; Vanessa Allen; H Roslyn Devlin; Matthew P Muller
Journal:  Emerg Infect Dis       Date:  2015-01       Impact factor: 6.883

7.  Molecular investigation of infection sources and transmission chains of brucellosis in Zhejiang, China.

Authors:  Heng Wang; Wei-Min Xu; Kuang-Ji Zhu; Su-Juan Zhu; Hong-Fang Zhang; Jia Wang; Yang Yang; Feng-Yao Shao; Neng-Ming Jiang; Zhen-Yang Tao; Hang-Yi Jin; Yi Tang; Liang-Liang Huo; Fang Dong; Zhen-Jun Li; Hua Ding; Zhi-Guo Liu
Journal:  Emerg Microbes Infect       Date:  2020-12       Impact factor: 7.163

Review 8.  Zika Virus Infection During Research Vaccine Development: Investigation of the Laboratory-Acquired Infection via Nanopore Whole-Genome Sequencing.

Authors:  Eunsik Bang; Sujin Oh; Ho Eun Chang; Il Seob Shin; Kyoung Un Park; Eu Suk Kim
Journal:  Front Cell Infect Microbiol       Date:  2022-03-07       Impact factor: 5.293

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.